By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MicroBiome Therapeutics LLC 

11001 W 120th Avenue
Suite 400
Broomfield  Colorado  80021  U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
MicroBiome Therapeutics LLC Presents Clinical Data On Diabetes Drug NM505 At American Diabetes Association's 75th Scientific Sessions And Reports Issuance Of NM505 Patent 6/9/2015 6:25:30 AM
MicroBiome Therapeutics LLC Receives Positive Response From FDA For Use Of Expedited Regulatory Pathway For Diabetes Drug Nm505 5/12/2015 7:20:24 AM
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015 9:20:07 AM
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015 6:46:04 AM
MicroBiome Therapeutics LLC Receives Notice Of Allowance For U.S. Patent Covering Glyceollin As A Treatment For Diabetes And Obesity 2/9/2015 9:07:44 AM
Positive Proof Of Concept Study Shows MicroBiome Therapeutics LLC' NM505 May Improve Tolerability Of Metformin In Type 2 Diabetes 9/26/2014 7:44:36 AM
MicroBiome Therapeutics LLC' NM504 Improves Blood Glucose Control In Diabetes And Prediabetes 6/23/2014 12:28:04 PM
Data Presented At ICE/ENDO 2014 Shows MicroBiome Therapeutics LLC' NM504 Improves Blood Glucose Control In Diabetes And Prediabetes 6/23/2014 6:36:31 AM
MicroBiome Therapeutics LLC Cites Proof Of Concept Study Showing Metformin Improves Glycemic Control In Diabetes By Shifting The GI Microbiome 6/17/2014 11:58:40 AM
MicroBiome Therapeutics LLC' Clinical Trial Data For NM504 In Type 2 Diabetes Has Been Accepted For Presentation At ICE/ENDO 2014 4/8/2014 9:11:33 AM
12
//-->